61. The effect of autoimmune blistering diseases on work productivity. (29th May 2018) Authors: Wang, E.Q.; Radjenovic, M.; Castrillón, M.A.; Feng, G.H.Y.; Murrell, D.F. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 11(2018) Page Start: 1959 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
62. The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa. (3rd October 2016) Authors: Jain, S.V.; Harris, A.G.; Su, J.C.; Orchard, D.; Warren, L.J.; McManus, H.; Murrell, D.F. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 4(2017) Page Start: 692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
63. Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic. (19th March 2021) Authors: Kasperkiewicz, M.; Schmidt, E.; Amagai, M.; Fairley, J.A.; Joly, P.; Murrell, D.F.; Payne, A.S.; Yale, M.L.; Zillikens, D.; Woodley, D.T. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 7(2021) Page Start: e412 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
64. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV). (24th August 2020) Authors: Joly, P.; Horvath, B.; Patsatsi, Α; Uzun, S.; Bech, R.; Beissert, S.; Bergman, R.; Bernard, P.; Borradori, L.; Caproni, M.; Caux, F.; Cianchini, G.; Daneshpazhooh, M.; De, D; Dmochowski, M.; Drenovska, K.; Ehrchen, J.; Feliciani, C.; Goebeler, M.; Groves, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 9(2020) Page Start: 1900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
65. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. (8th July 2013) Authors: Kim, M.; Li, M.; Intong, L.R.A.; Tran, K.; Melbourne, W.; Marucci, D.; Bucci, J.; de Souza, P.; Mallesara, G.; Murrell, D.F. Journal: British journal of dermatology Issue: Volume 169:Number 1(2013:Jul.) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
66. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. (1st March 2018) Authors: Drucker, A.M.; Eyerich, K.; de Bruin‐Weller, M.S.; Thyssen, J.P.; Spuls, P.I.; Irvine, A.D.; Girolomoni, G.; Dhar, S.; Flohr, C.; Murrell, D.F.; Paller, A.S.; Guttman‐Yassky, E. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: 768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
67. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. (1st March 2018) Authors: Drucker, A.M.; Eyerich, K.; de Bruin‐Weller, M.S.; Thyssen, J.P.; Spuls, P.I.; Irvine, A.D.; Girolomoni, G.; Dhar, S.; Flohr, C.; Murrell, D.F.; Paller, A.S.; Guttman‐Yassky, E. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: e232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
68. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. (28th January 2018) Authors: Drucker, A.M.; Eyerich, K.; de Bruin‐Weller, M.S.; Thyssen, J.P.; Spuls, P.I.; Irvine, A.D.; Girolomoni, G.; Dhar, S.; Flohr, C.; Murrell, D.F.; Paller, A.S.; Guttman‐Yassky, E. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: 768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
69. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. (29th March 2018) Authors: Drucker, A.M.; Eyerich, K.; de Bruin‐Weller, M.S.; Thyssen, J.P.; Spuls, P.I.; Irvine, A.D.; Girolomoni, G.; Dhar, S.; Flohr, C.; Murrell, D.F.; Paller, A.S.; Guttman‐Yassky, E. Journal: British journal of dermatology Issue: Volume 178:Number 3(2018) Page Start: e232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
70. Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus. (30th July 2019) Authors: Yang, A.; Xuan, R.; Melbourne, W.; Tran, K.; Murrell, D.F. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 1(2020) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗